Jefferies Reiterates a Buy Rating on Boston Scientific Corporation (BSX), Sets a $130 PT
Boston Scientific Corporation (NYSE:BSX) is one of the best stocks to invest in for beginners.
Boston Scientific Corp (BSX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 7,705,384 | $827,635,383 | +14% | 0.33% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 7,497,657 | $805,323,340 | -6% | 0.91% |
| 3. | D E Shaw D. E. Shaw | 6,755,151 | $725,570,768 | +76% | 0.51% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 6,529,918 | $701,378,492 | -4% | 0.5% |
| 5. | Citadel Investment Group Ken Griffin | 5,404,305 | $580,476,400 | -1% | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $90.29 | 50 | $4,514.60 | 148,168 | 2024-12-03 | Filing | |
| $41.98 | 25,000 | $1,049,450.00 | 25,000 | 2021-11-15 | Filing | |
| $27.50 | 13 | $357.50 | 32,337 | 2017-09-01 | Filing | |
| $27.80 | 30 | $834.00 | 32,324 | 2017-06-16 | Filing | |
| $25.52 | 29 | $740.08 | 32,294 | 2017-04-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $104.63 | 50,000 | $5,231,670.00 | 178,342 | 2025-08-01 | Filing | |
| $104.63 | 17,313 | $1,811,519.79 | 23,600 | 2025-08-01 | Filing | |
| $106.99 | 2,901 | $310,377.99 | 2,081 | 2025-07-29 | Filing | |
| $106.03 | 4,000 | $424,120.40 | 18,479 | 2025-07-25 | Filing | |
| $106.97 | 50,000 | $5,348,315.00 | 178,342 | 2025-07-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 146,687,740 | $15,755,730,087 | 0.3% | |
| 2. | 137,134,110 | $14,729,574,755 | 0.24% | |
| 3. | 108,310,577 | $11,633,639,055 | 0.66% | |
| 4. | 65,191,864 | $7,002,258,112 | 0.26% | |
| 5. | 34,662,722 | $3,723,122,970 | 2.95% |
News See All
FDA Monitors Safety Issue with Boston Scientific Defibrillator Leads
Boston Scientific Corporation (NYSE:BSX) is one of the best high-volume stocks to invest in.
12 Best Stocks to Invest in For Beginners
On August 14, Paul Hickey, Bespoke Investment Group co-founder, appeared on CNBC’s ‘Closing Bell: Overtime’ to talk about what he’s seeing in market breadth as the S&P 500 and NASDAQ close at ...
14 Best High Volume Stocks to Invest In
On August 5, Stephanie Link, Hightower Advisors' chief investment strategist, joined 'Squawk Box' on CNBC to suggest that she expects market volatility for the next 2 months, but set up into year-end ...
Oppenheimer Lifts Boston Scientific (BSX) PT to $118 Following Strong Q2 Results
Boston Scientific Corporation (NYSE:BSX) is one of the most profitable growth stocks to buy according to billionaires.
Truist Boosts Boston Scientific (BSX) Price Target After Strong Quarter
Boston Scientific Corporation (NYSE:BSX) ranks among the best medical stocks to buy according to analysts.
11 Best Medical Stocks to Buy According to Analysts
As macroeconomic headwinds, regulatory reforms, and geopolitical concerns converge in the second half of 2025, PwC predicts that the health industry's resilience and adaptability will be put to the test...
RBC Capital Raises PT on Boston Scientific Corporation (BSX) to $125 From $120
Boston Scientific Corporation (NYSE:BSX) is one of the top low volatility healthcare stocks to buy now.
Boston Scientific Corporation (BSX) Is One Of The Most Reliable Companies, Says Jim Cramer
Boston Scientific Corporation (NYSE:BSX) is one of the biggest medical device companies in the world. Its shares have gained 18.9% year to date, with July proving to be a good month.
TD Cowen Reiterates a Buy Rating on Boston Scientific Corporation (BSX)
Boston Scientific Corporation (NYSE:BSX) is one of the best strong buy healthcare stocks to buy now.
Billionaire Hedge Funds
